Your browser doesn't support javascript.
loading
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation.
Ruggeri, Annalisa; De Wreede, Liesbeth C; Müller, Carlheinz R; Crivello, Pietro; Bonneville, Edouard F; Petersdorf, Effie W; Socié, Gerard; Dubois, Valérie; Niittyvuopio, Riitta; Peräsaari, Juha; Yakoub-Agha, Ibrahim; Cornelissen, Jan J; Wieten, Lotte; Gedde-Dahl, Tobias; Forcade, Edouard; Crawley, Charles R; Marsh, Steven G E; Gandemer, Virginie; Tholouli, Eleni; Bulabois, Claude-Eric; Huynh, Anne; Choi, Goda; Deconinck, Eric; Itäla-Remes, Maija; Lenhoff, Stig; Bengtsson, Mats; Johansson, Jan-Erik; Van Gorkom, Gwendolyn; Hoogenboom, Jorinde D; Vago, Luca; Rocha, Vanderson; Bonini, Chiara; Chabannon, Christian; Fleischhauer, Katharina.
Afiliação
  • Ruggeri A; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden.
  • De Wreede LC; Leiden University Medical Center, Leiden.
  • Müller CR; Zentrales Knochenmarkspender-Register Deutschland, Ulm.
  • Crivello P; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen.
  • Bonneville EF; Leiden University Medical Center, Leiden.
  • Petersdorf EW; Fred Hutchinson Cancer Research Center, Seattle.
  • Socié G; Hôpital St. Louis, Paris.
  • Dubois V; Histocompatibility Laboratory, EFS Lyon.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki.
  • Peräsaari J; Clinical Laboratory Services, Histocompatibility Testing, Finnish Red Cross Blood Service, Helsinki.
  • Yakoub-Agha I; CHU de Lille, Lille.
  • Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam.
  • Wieten L; Transplantation Immunology, Maastricht University Medical Center, Maastricht.
  • Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo.
  • Forcade E; CHU Bordeaux, Pessac.
  • Crawley CR; Addenbrookes Hospital, Cambridge.
  • Marsh SGE; Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London,.
  • Gandemer V; Centre Hospitalier Universitaire de Rennes, Rennes.
  • Tholouli E; Manchester Royal Infirmary, Manchester.
  • Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble.
  • Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Toulouse.
  • Choi G; University Medical Center Groningen (UMCG), Groningen.
  • Deconinck E; Hopital Jean Minjoz, Besancon.
  • Itäla-Remes M; Turku University Hospital, Turku.
  • Lenhoff S; Skanes University Hospital, Lund.
  • Bengtsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala.
  • Johansson JE; Sahlgrenska University Hospital, Goeteborg.
  • Van Gorkom G; University Hospital Maastricht, Maastricht.
  • Hoogenboom JD; EBMT Leiden Study Unit, Leiden.
  • Vago L; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden.
  • Rocha V; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31) of the Service of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, SP.
  • Bonini C; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden.
  • Chabannon C; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille.
  • Fleischhauer K; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen. katharina.fleischhauer@uk-essen.de.
Haematologica ; 108(2): 645-652, 2023 02 01.
Article em En | MEDLINE | ID: mdl-35546480

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article